Skip to content
Screener

Zymeworks ZYME Total Revenue

Total Revenue at other companies

Pfizer logo
PfizerPFE
$15.03B+2.6%
Amgen logo
AmgenAMGN
$10.05B+9.5%
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
$0
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$4.05M-76.3%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$63.69M+33.7%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$39.66M+53.3%

Segments

By product

See full
Other drug supply$1.66M
Royalties$1.59M
Drug supply for ongoing studies$791K
Development support payments$291K
Milestone revenue$0
Option exercise fee$0

Other financials

Income statement

See full
Operating income-$42.2M-6,158%
Net income-$45.0M-2,043%
EPS (diluted)-$0.62-2,167%

Balance sheet

See full
Cash & equivalents$179.4M+82.6%
Total debt$16.0M-14.3%
Total equity$80.4M-76.0%
Total assets$397.0M-2.8%

Cash flow

See full
Operating cash flow-$31.9M-365%
CapEx$216.0K+1,250%
Free cash flow-$31.9M-376%

Valuation

See full
Market cap$1.7B+83.2%
Enterprise value$1.54B+81.1%
P/S45.8×+38.3×

Profitability

See full
Operating margin-419%-518pp
Net margin-404%-489pp
FCF margin-324.7%-366pp

Returns & leverage

See full
Return on equity-72.3%-117pp
Debt / equity0.2×+0.1×
Current ratio6.3×-1.4×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Zymeworks’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:11 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001937653-26-000047
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Revenue
Research and development collaborations$4,590$48,726$6,998$75,836
Operating expenses:
Research and development27,43534,44961,89270,187
General and administrative19,33514,95134,40431,936
Total operating expenses46,77049,40096,296102,123
Loss from operations(42,180)(674)(89,298)(26,287)
Other (expense) income:

Item 1. Financial Statements

FAQ

What is Zymeworks's total revenue?
Zymeworks (ZYME) reported total revenue of $4.59M in Q2 2026.
How has Zymeworks's total revenue changed year-over-year?
Zymeworks's total revenue decreased by 90.6% year-over-year, from $48.73M to $4.59M.
What is the long-term trend for Zymeworks's total revenue?
Over 3 years (2022 to 2025), Zymeworks's total revenue has grown at a -36.4% compound annual growth rate (CAGR), from $412.48M to $105.97M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Zymeworks's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude